These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The impact of age on rejection in kidney transplantation. de Fijter JW Drugs Aging; 2005; 22(5):433-49. PubMed ID: 15903355 [TBL] [Abstract][Full Text] [Related]
14. Society for Maternal-Fetal Medicine Consult Series #66: Prepregnancy evaluation and pregnancy management of patients with solid organ transplants. ; Irani RA; Coscia LA; Chang E; Lappen JR; Am J Obstet Gynecol; 2023 Aug; 229(2):B10-B32. PubMed ID: 37088276 [TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? Höcker B; Tönshoff B Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul. Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A Transpl Infect Dis; 2020 Oct; 22(5):e13371. PubMed ID: 32657540 [TBL] [Abstract][Full Text] [Related]
17. Basiliximab: a review of its use as induction therapy in renal transplantation. Chapman TM; Keating GM Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658 [TBL] [Abstract][Full Text] [Related]
18. Induction Versus Maintenance Immunosuppression After Intestinal Transplant: Determining Which Treatment Most Impacts Long-Term Patient And Graft Survival. Gentilini MV; Perez-Illidge L; Pedraza N; Nemirovsky SI; Fernandez MF; Ramisch D; Solar H; Rumbo M; Rumbo C; Gondolesi GE Exp Clin Transplant; 2022 Dec; 20(12):1105-1113. PubMed ID: 36718010 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Marcén R Drugs; 2009 Nov; 69(16):2227-43. PubMed ID: 19852526 [TBL] [Abstract][Full Text] [Related]
20. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT. Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G; Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]